A Changing Healthcare Landscape is Pressuring Costs on the Industry, But Technology is Swinging in With a Resolution

 

With an evolving healthcare landscape, organizations face increasing pressure on their profit margins, stemming from rising labor and supply costs, declining reimbursements, and the intricate dynamics of healthcare billing. Striking a balance amid these challenges requires innovative strategies and tools to measure, motivate, and retain the highest performers – the human capital that ultimately drives organizational success. 

At the intersection of technology and people management, novel software solutions have emerged, designed to objectively assess performance, thereby helping to ensure that high-value contributors remain motivated and engaged. Showcasing his presentation for “Highway to Health,” Matt Seefeld, Executive Vice President at MedEvolve, understands the nuances of those deeper critical issues as a thought leader pioneering fresh solutions to mitigate the pressures of the modern healthcare landscape.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…